Theravance Biopharma, Inc.

TBPHNasdaq· Pharmaceutical Preparations

Price History

Revenue

$64.4M

▲ 12.1% YoY

Net Income

-$56.4M

▼ 2.2% YoY

EPS

$-1.15

▼ 15.0% YoY

Cash

$37.8M

▼ 4.4% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.